OPRX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
20.5M
+3.3%
19.8M
-38.4%
32.2M
+23.7%
26.1M
-10.7%
29.2M
Cost of Revenue
4.8M
-2.0%
4.9M
-39.6%
8.1M
-4.8%
8.6M
-19.0%
10.6M
Gross Profit
15.7M
+5.1%
14.9M
-38.0%
24.1M
+37.6%
17.5M
-6.0%
18.6M
Operating Expenses
15.8M
+8.5%
14.5M
-6.4%
15.5M
+0.4%
15.5M
+0.2%
15.4M
R&D
3.3M
-3.8%
3.4M
0
0
-100.0%
3.1M
SG&A
11.4M
+13.6%
10.1M
-28.5%
14.1M
-2.1%
14.4M
+27.7%
11.3M
Operating Income
-88000
-122.2%
396.0K
-95.4%
8.6M
+318.0%
2.0M
-36.1%
3.2M
EBITDA
976.0K
-33.2%
1.5M
-85.4%
10.0M
+219.9%
3.1M
-26.9%
4.3M
Net Income
-703000
-42.0%
-495000
-109.9%
5.0M
+544.4%
779.0K
-49.2%
1.5M
EPS (Basic)
$-0.04
-33.3%
$-0.03
-111.1%
$0.27
+575.0%
$0.04
-50.0%
$0.08
EPS (Diluted)
$-0.04
-33.3%
$-0.03
-111.5%
$0.26
+550.0%
$0.04
-50.0%
$0.08
Shares (Diluted)
18.8M
+0.1%
18.8M
-1.5%
19.0M
-2.1%
19.5M
+2.3%
19.0M
OptimizeRx (OPRX) โ€” Financials